Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LMP744 |
Synonyms | |
Therapy Description |
LMP744 is an inhibitor of TOP1, which upon binding results in stability of cleaved Top1, thereby potentially leading to cell cycle arrest and apoptosis of cancer cells (PMID: 31227499). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
LMP744 | LMP-744|LMP 744 | TOPO1 inhibitor 11 | LMP744 is an inhibitor of TOP1, which upon binding results in stability of cleaved Top1, thereby potentially leading to cell cycle arrest and apoptosis of cancer cells (PMID: 31227499). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03030417 | Phase I | LMP744 | Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas | Completed | USA | 0 |